ResearcherNew York UniversityActive in the last 2 years
Wei Wang
Matched on ORCID iD 0000-0002-9525-2264; OpenAlex author ID A5100392131. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- The TMBIM1-YBX1 axis orchestrates MDSC recruitment and immunosuppressive microenvironment in pancreatic cancer. Co-author DOI 10.7150/thno.111180↗
- Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Co-author DOI 10.1038/s41388-023-02606-9↗
- BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Co-author DOI 10.1038/s41388-022-02425-4↗
- RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2018.10.006↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Deirdre Jill Cohen · 3 shared papers, 2018–2023 · strength 0.29
- Paper Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastati… DOI 10.1038/s41388-023-02606-9↗
- Paper BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary p… DOI 10.1038/s41388-022-02425-4↗
- Paper RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. DOI 10.1016/j.ccell.2018.10.006↗
- Berk Aykut · 3 shared papers, 2018–2023 · strength 0.29
- Paper Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastati… DOI 10.1038/s41388-023-02606-9↗
- Paper BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary p… DOI 10.1038/s41388-022-02425-4↗
- Paper RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. DOI 10.1016/j.ccell.2018.10.006↗
- Joshua Leinwand · 3 shared papers, 2018–2023 · strength 0.29
- Paper Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastati… DOI 10.1038/s41388-023-02606-9↗
- Paper BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary p… DOI 10.1038/s41388-022-02425-4↗
- Paper RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. DOI 10.1016/j.ccell.2018.10.006↗
- George Miller · 3 shared papers, 2018–2023 · strength 0.29
- Paper Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastati… DOI 10.1038/s41388-023-02606-9↗
- Paper BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary p… DOI 10.1038/s41388-022-02425-4↗
- Paper RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. DOI 10.1016/j.ccell.2018.10.006↗
- Xuhui Tong · 1 shared paper, 2025 · strength 0.28
- Xianjun Yu · 1 shared paper, 2025 · strength 0.28
- Jing Yang · 1 shared paper, 2025 · strength 0.28
- Mingming Xiao · 1 shared paper, 2025 · strength 0.28
- Si Shi · 1 shared paper, 2025 · strength 0.28
- Gregor Werba · 2 shared papers, 2022–2023 · strength 0.24
- Paper Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastati… DOI 10.1038/s41388-023-02606-9↗
- Paper BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary p… DOI 10.1038/s41388-022-02425-4↗
- Brian E. Diskin · 2 shared papers, 2022–2023 · strength 0.24
- Paper Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastati… DOI 10.1038/s41388-023-02606-9↗
- Paper BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary p… DOI 10.1038/s41388-022-02425-4↗
- Emma Kurz · 1 shared paper, 2018 · strength 0.05
- Fei Li · 1 shared paper, 2018 · strength 0.05
- Philip A. Harris · 1 shared paper, 2018 · strength 0.05
- Atsuo Ochi · 1 shared paper, 2018 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.